US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.8500
  • +0.0200+1.09%
Close Dec 23 16:00 ET
  • 1.8400
  • -0.0100-0.54%
Post 16:47 ET
403.64MMarket Cap-8.41P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-10.98%37.43M
-22.58%43.65M
-18.49%32.61M
-33.46%194.62M
0.74%56.2M
-13.69%42.05M
-55.39%56.38M
-35.16%40.01M
38.19%292.48M
-3.29%55.78M
Operating revenue
-10.98%37.43M
-22.58%43.65M
-18.49%32.61M
-33.46%194.62M
0.74%56.2M
-13.69%42.05M
-55.39%56.38M
-35.16%40.01M
38.19%292.48M
-3.29%55.78M
Cost of revenue
-21.37%14.16M
-1.37%17.05M
-42.52%11.61M
-13.34%74.15M
644.33%18.67M
-52.96%18.01M
-7.08%17.28M
-35.59%20.19M
-43.21%85.57M
-107.20%-3.43M
Gross profit
-3.20%23.27M
-31.95%26.6M
5.99%21M
-41.78%120.47M
-36.61%37.53M
130.39%24.04M
-63.72%39.09M
-34.72%19.82M
239.32%206.92M
489.16%59.21M
Operating expense
-3.07%35.77M
-26.68%35.33M
-20.81%35.88M
-38.72%166.55M
-42.48%36.16M
-39.16%36.9M
-18.56%48.18M
-49.01%45.31M
-16.50%271.76M
-16.62%62.86M
Selling and administrative expenses
16.76%26.52M
-0.44%26.92M
1.54%25.44M
-27.68%100.23M
-14.95%25.44M
-28.78%22.71M
-16.14%27.04M
-43.48%25.05M
-20.41%138.6M
-33.25%29.91M
Research and development costs
-36.33%8.49M
-62.14%7.65M
-50.57%9.73M
-51.47%63.08M
-69.27%9.87M
-52.44%13.33M
-22.40%20.2M
-55.09%19.69M
-12.08%129.99M
8.60%32.1M
Other operating expenses
-11.00%769K
-19.70%762K
25.18%711K
1.95%3.24M
0.47%856K
16.29%864K
6.39%949K
-17.44%568K
-9.00%3.18M
-17.20%852K
Operating profit
2.81%-12.51M
4.02%-8.73M
41.63%-14.88M
28.95%-46.08M
137.67%1.37M
74.38%-12.87M
-118.70%-9.09M
56.42%-25.49M
75.48%-64.85M
94.42%-3.65M
Net non-operating interest income expense
-372.41%-6.66M
-30.88%-2.15M
-60.03%-2.5M
61.55%-6.03M
13.33%-1.42M
64.32%-1.41M
67.40%-1.64M
69.16%-1.56M
21.31%-15.69M
67.81%-1.64M
Non-operating interest expense
372.41%6.66M
30.88%2.15M
60.03%2.5M
-61.55%6.03M
-13.33%1.42M
-64.32%1.41M
-67.40%1.64M
-69.16%1.56M
--15.69M
--1.64M
Other net income (expense)
-311.79%-873K
620.91%2.29M
-446.02%-609K
101.33%182K
183.50%658K
-361.73%-212K
96.88%-440K
-84.48%176K
-667.23%-13.69M
-240.71%-788K
Gain on sale of security
---856K
--2.33M
---129K
----
----
----
----
----
----
----
Special income (charges)
--0
--0
-442.45%-575K
95.81%-705K
--0
84.44%-169K
97.04%-430K
---106K
---16.84M
---1.22M
-Less：Restructuring and merger&acquisition
--0
--0
-45.28%58K
-98.86%181K
--0
-6.11%169K
-100.65%-94K
--106K
--15.93M
--1.22M
-Less:Other special charges
----
----
--517K
-42.16%524K
--0
----
--524K
----
--906K
--0
Other non- operating income (expenses)
60.47%-17K
-290.00%-39K
-66.31%95K
-71.81%887K
51.61%658K
-103.68%-43K
-102.43%-10K
-75.13%282K
30.32%3.15M
-22.50%434K
Income before tax
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
Income tax
Net income
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
Net income continuous Operations
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
Minority interest income
Net income attributable to the parent company
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
Basic earnings per share
-25.00%-0.1
33.33%-0.04
40.00%-0.09
46.15%-0.28
108.07%0.0032
72.41%-0.08
-137.50%-0.06
57.14%-0.15
69.41%-0.52
90.00%-0.04
Diluted earnings per share
-25.00%-0.1
33.33%-0.04
40.00%-0.09
46.15%-0.28
108.05%0.0032
72.41%-0.08
-140.00%-0.06
57.14%-0.15
69.41%-0.52
90.00%-0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -10.98%37.43M-22.58%43.65M-18.49%32.61M-33.46%194.62M0.74%56.2M-13.69%42.05M-55.39%56.38M-35.16%40.01M38.19%292.48M-3.29%55.78M
Operating revenue -10.98%37.43M-22.58%43.65M-18.49%32.61M-33.46%194.62M0.74%56.2M-13.69%42.05M-55.39%56.38M-35.16%40.01M38.19%292.48M-3.29%55.78M
Cost of revenue -21.37%14.16M-1.37%17.05M-42.52%11.61M-13.34%74.15M644.33%18.67M-52.96%18.01M-7.08%17.28M-35.59%20.19M-43.21%85.57M-107.20%-3.43M
Gross profit -3.20%23.27M-31.95%26.6M5.99%21M-41.78%120.47M-36.61%37.53M130.39%24.04M-63.72%39.09M-34.72%19.82M239.32%206.92M489.16%59.21M
Operating expense -3.07%35.77M-26.68%35.33M-20.81%35.88M-38.72%166.55M-42.48%36.16M-39.16%36.9M-18.56%48.18M-49.01%45.31M-16.50%271.76M-16.62%62.86M
Selling and administrative expenses 16.76%26.52M-0.44%26.92M1.54%25.44M-27.68%100.23M-14.95%25.44M-28.78%22.71M-16.14%27.04M-43.48%25.05M-20.41%138.6M-33.25%29.91M
Research and development costs -36.33%8.49M-62.14%7.65M-50.57%9.73M-51.47%63.08M-69.27%9.87M-52.44%13.33M-22.40%20.2M-55.09%19.69M-12.08%129.99M8.60%32.1M
Other operating expenses -11.00%769K-19.70%762K25.18%711K1.95%3.24M0.47%856K16.29%864K6.39%949K-17.44%568K-9.00%3.18M-17.20%852K
Operating profit 2.81%-12.51M4.02%-8.73M41.63%-14.88M28.95%-46.08M137.67%1.37M74.38%-12.87M-118.70%-9.09M56.42%-25.49M75.48%-64.85M94.42%-3.65M
Net non-operating interest income expense -372.41%-6.66M-30.88%-2.15M-60.03%-2.5M61.55%-6.03M13.33%-1.42M64.32%-1.41M67.40%-1.64M69.16%-1.56M21.31%-15.69M67.81%-1.64M
Non-operating interest expense 372.41%6.66M30.88%2.15M60.03%2.5M-61.55%6.03M-13.33%1.42M-64.32%1.41M-67.40%1.64M-69.16%1.56M--15.69M--1.64M
Other net income (expense) -311.79%-873K620.91%2.29M-446.02%-609K101.33%182K183.50%658K-361.73%-212K96.88%-440K-84.48%176K-667.23%-13.69M-240.71%-788K
Gain on sale of security ---856K--2.33M---129K----------------------------
Special income (charges) --0--0-442.45%-575K95.81%-705K--084.44%-169K97.04%-430K---106K---16.84M---1.22M
-Less：Restructuring and merger&acquisition --0--0-45.28%58K-98.86%181K--0-6.11%169K-100.65%-94K--106K--15.93M--1.22M
-Less:Other special charges ----------517K-42.16%524K--0------524K------906K--0
Other non- operating income (expenses) 60.47%-17K-290.00%-39K-66.31%95K-71.81%887K51.61%658K-103.68%-43K-102.43%-10K-75.13%282K30.32%3.15M-22.50%434K
Income before tax -38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M
Income tax
Net income -38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M
Net income continuous Operations -38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M
Minority interest income
Net income attributable to the parent company -38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.30%-20.04M23.18%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M
Basic earnings per share -25.00%-0.133.33%-0.0440.00%-0.0946.15%-0.28108.07%0.003272.41%-0.08-137.50%-0.0657.14%-0.1569.41%-0.5290.00%-0.04
Diluted earnings per share -25.00%-0.133.33%-0.0440.00%-0.0946.15%-0.28108.05%0.003272.41%-0.08-140.00%-0.0657.14%-0.1569.41%-0.5290.00%-0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Bit Origin
BTOG
+5.56%
Bakkt Holdings
BKKT
+0.83%
Bitdeer Technologies
BTDR
+0.15%
SATO TECHNOLOGIES CORP
CCPUF
0.00%
FRMO CORP
FRMO
-0.38%

Unlock the Full List